The Pill and Blood Clots: What Is the Actual Risk?
Reviewed by Usama Ali, MPharm (GPhC: 2224726). Last reviewed: October 2026.

In a nutshell
The combined pill carries a small increased risk of blood clots: around 5 to 12 per 10,000 users per year depending on the type (5 to 7 for levonorgestrel pills), compared to 2 per 10,000 in non-users. For context, the risk during pregnancy is around 29 per 10,000.
The mini pill contains no oestrogen and is not thought to raise the risk of blood clots in the way the combined pill does. It is a suitable alternative if clot risk is a concern.
Quick facts
- Combined pill: roughly 5 to 12 clots per 10,000 users a year, lowest (5 to 7) for levonorgestrel.
- Non-users: around 2 per 10,000. Pregnancy: around 29 per 10,000.
- Levonorgestrel pills (Microgynon, Levest) are in the lowest-risk group.
- The mini pill is not thought to raise blood clot risk.
Discussing clot risk with a pharmacist
Both types of pill are free on the NHS through the Pharmacy Contraception Service: the combined pill for people aged 16 to 49 and the mini pill, which is not thought to raise clot risk, for people aged 16 to 54. A GPhC-registered pharmacist checks your personal risk factors by phone. Supply depends on that assessment.
What is the actual risk?
Blood clots are one of the most common concerns people have about the combined pill. The concern is understandable, but the actual numbers are often misunderstood. Here is what the data says.
In women who do not use hormonal contraception and are not pregnant, about 2 in every 10,000 develop a venous blood clot (deep vein thrombosis or pulmonary embolism) per year. Among women taking a combined pill containing levonorgestrel (such as Microgynon or Rigevidon), that figure rises to approximately 5 to 7 per 10,000 per year. Among women taking pills containing desogestrel, gestodene, or drospirenone, the figure is around 9 to 12 per 10,000 per year. These figures come from the FSRH Combined Hormonal Contraception guideline.
To be clear: the risk is real, but it is small. For every 10,000 women taking a levonorgestrel combined pill for a year, about 5 to 7 will develop a clot. The vast majority will not.
How does the risk vary by pill type?
| Pill type | Approximate VTE risk per 10,000 users per year |
|---|---|
| No hormonal contraception (baseline) | About 2 |
| Combined pill with levonorgestrel (Microgynon, Rigevidon) | 5 to 7 |
| Combined pill with desogestrel or gestodene (Marvelon, Femodene) | 9 to 12 |
| Combined pill with drospirenone (Yasmin, Lucette) | 9 to 12 |
| Mini pill (any type) | Not thought to be raised (the evidence is limited) |
| Pregnancy | About 29 |
| First 6 weeks after birth | About 300 to 400 |
The table shows why levonorgestrel pills like Microgynon are usually the first choice combined pill. They are in the lowest clot risk group. If a different progestogen is used (such as drospirenone in Yasmin), it is because the clinical benefit (for example, improvement in acne or bloating) justifies the slightly higher risk.
Who is at higher risk?
Most people who take the combined pill will never develop a blood clot. But some factors increase your baseline risk, and your pharmacist checks all of these before prescribing.
Family history. If your parent, brother, sister or child has had a blood clot in a vein, at any age, the combined pill is not usually recommended. Your pharmacist will ask about this and can suggest the mini pill instead.
Personal history. If you have had a blood clot yourself, the combined pill is not suitable. The mini pill is the standard alternative.
Smoking. Smoking and the combined pill together significantly increase cardiovascular risk, particularly if you are over 35. If you smoke or vape and are 35 or over, or stopped less than a year ago, the combined pill is not prescribed. If you smoke and are under 35, the risk is assessed individually.
BMI. A BMI of 35 or above is usually a reason not to prescribe the combined pill, because obesity independently raises the risk of blood clots.
Immobility and surgery. Prolonged immobility (long flights, bed rest, major surgery) increases clot risk. The combined pill should usually be stopped 4 weeks before a planned operation lasting more than 30 minutes, any operation on the legs, or one that keeps a leg still for a long time, and restarted at least 2 weeks after you are fully mobile. The mini pill does not need to be stopped.
Age. The risk of blood clots increases with age. UK guidance supports the combined pill up to age 50 for most people, and the NHS Pharmacy Contraception Service supplies it up to age 49.
These criteria come from the UK Medical Eligibility Criteria (UKMEC 2025), the same framework used by GPs and sexual health clinics.
What are the warning signs?
Blood clots are rare, but knowing the warning signs is important. Seek urgent medical help (call 999 or go to A&E) if you experience any of the following while taking the combined pill:
Deep vein thrombosis (DVT): painful swelling in one leg, usually the calf. The area may feel warm and look red or discoloured. This is different from normal muscle ache.
Pulmonary embolism (PE): sudden chest pain, difficulty breathing, or coughing up blood. A PE happens when a clot travels to the lungs. This is a medical emergency.
Stroke: a sudden severe headache unlike any you have had before, sudden confusion, difficulty speaking, sudden numbness or weakness on one side of the body, or sudden changes in your vision.
"We always explain the warning signs when we prescribe the combined pill for the first time," says Usama Ali, MPharm (GPhC: 2224726), pharmacist at Contraception Direct. "It is not about scaring you. It is about making sure you know what to look out for, so that if something did happen, you would recognise it quickly."
Does the mini pill raise the risk of blood clots?
The mini pill (progestogen-only pill) does not contain oestrogen. It is the oestrogen in the combined pill that increases clot risk, so the mini pill is not thought to raise the risk in the same way. That is why it is the usual alternative if you have had a clot or have clot risk factors.
If blood clot risk is a concern for you, whether because of family history, personal risk factors, or simply peace of mind, the mini pill is a safe and effective alternative. It is over 99% effective with perfect use, just like the combined pill.
For a comparison of the two types, read our guide on combined pill vs mini pill.
How does your pharmacist reduce the risk?
Every time the combined pill is prescribed through the NHS Pharmacy Contraception Service, your pharmacist runs through the UKMEC checklist. They check your blood pressure, BMI, smoking status, migraine history, family history of blood clots, personal history of cardiovascular disease, and current medications.
If any of these raise a concern, the combined pill is not supplied. Instead, your pharmacist recommends the mini pill or refers you for further assessment if needed. This is the same process used by GPs and sexual health clinics.
For repeat supplies, your pharmacist reviews these factors again at each consultation. Blood pressure and BMI are rechecked regularly. If anything has changed, they adjust their recommendation.
Putting the risk in context
It is worth remembering that unintended pregnancy also carries risks, and the risks of pregnancy are higher than the risks of taking the pill. Blood clot risk during pregnancy is around 29 per 10,000, compared to 5 to 7 per 10,000 on a levonorgestrel combined pill.
The combined pill has been used safely by millions of people for over 60 years. It is well studied, well understood, and well monitored. The role of your pharmacist is to make sure it is safe for you as an individual, not just as a population average.
If you have questions about your personal risk, book a free consultation with Contraception Direct. Your pharmacist can explain the numbers in the context of your own health and help you decide whether the combined pill or the mini pill is the better option for you.
Frequently asked questions
- Does the pill cause blood clots?
- The combined pill slightly increases the risk of blood clots, but the overall risk is still very low. Around 5 to 12 in 10,000 combined pill users per year develop a clot, depending on the type of pill (5 to 7 for levonorgestrel pills such as Microgynon), compared to 2 in 10,000 non-users. The mini pill does not carry this increased risk.
- Which pill has the lowest blood clot risk?
- Combined pills containing levonorgestrel (such as Microgynon and Rigevidon) are among the combined pills with the lowest blood clot risk, along with those containing norethisterone or norgestimate. The mini pill does not contain oestrogen and is not thought to raise blood clot risk in the way the combined pill does. If clot risk is a concern, the mini pill is a suitable alternative.
- Does the mini pill cause blood clots?
- It is not thought to. The mini pill (progestogen-only pill) does not contain oestrogen, and the limited evidence available does not link it to blood clots. It is a suitable option if blood clot risk is a concern, whether because of family history, personal risk factors, or simply peace of mind. It is over 99% effective with perfect use.
- Am I at higher risk of blood clots on the pill?
- Some factors increase your risk: a family history of blood clots, being 35 or over and smoking, having a BMI of 35 or above, recent surgery or immobility, or a personal history of clots. Your pharmacist checks these before prescribing the combined pill.
- Should I stop the pill before surgery?
- Usually, if it is a planned operation lasting more than 30 minutes, any operation on your legs, or one that will keep a leg still for a long time. The combined pill should be stopped 4 weeks before and restarted at least 2 weeks after you are fully mobile again (UKMEC 2025); the mini pill does not need to be stopped. This does not apply to minor procedures with a short anaesthetic, such as having a tooth out. Always tell your surgical team you take the pill and follow their advice.
- Can I take the pill if my family has a history of blood clots?
- It depends. If your parent, brother, sister or child has had a blood clot in a vein, at any age, the combined pill is not usually recommended under current UK guidance (UKMEC 2025). Your pharmacist will check your family history and can recommend the mini pill instead.
- What are the warning signs of a blood clot?
- Seek urgent medical help for: painful swelling in one leg (especially the calf), sudden chest pain or difficulty breathing, a sudden severe headache unlike any you have had before, or sudden changes in your vision. Call 999 or go to A&E.
This information is for general guidance only and does not replace advice from a clinician, pharmacist, or doctor. A clinician will review your consultation before any medication is supplied.
References
- FSRH. Combined Hormonal Contraception Clinical Guideline, January 2019 (amended October 2023).
- FSRH. Venous thromboembolism and hormonal contraception. FSRH statement, 2014 (reviewed 2019).
- CoSRH. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2025), December 2025.
- BNF. Combined hormonal contraceptives. British National Formulary.
- NHS. Risks of the combined pill.
Concerned about your risk?
Book a free phone consultation. Your pharmacist will review your personal risk factors and recommend the right option for you.
Confidential. No GP needed. Takes about 10 minutes.